U.S. flag

An official website of the United States government

NM_000128.4(F11):c.1853T>G (p.Ile618Ser) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Dec 11, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000059022.2

Allele description [Variation Report for NM_000128.4(F11):c.1853T>G (p.Ile618Ser)]

NM_000128.4(F11):c.1853T>G (p.Ile618Ser)

Genes:
F11-AS1:F11 antisense RNA 1 [Gene - HGNC]
F11:coagulation factor XI [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q35.2
Genomic location:
Preferred name:
NM_000128.4(F11):c.1853T>G (p.Ile618Ser)
HGVS:
  • NC_000004.12:g.186288589T>G
  • NG_008051.1:g.27626T>G
  • NM_000128.4:c.1853T>GMANE SELECT
  • NP_000119.1:p.Ile618Ser
  • NP_000119.1:p.Ile618Ser
  • LRG_583t1:c.1853T>G
  • LRG_583:g.27626T>G
  • LRG_583p1:p.Ile618Ser
  • NC_000004.11:g.187209743T>G
  • NM_000128.3:c.1853T>G
  • NR_033900.1:n.905A>C
  • P03951:p.Ile618Ser
Protein change:
I618S
Links:
UniProtKB: P03951#VAR_054906; UniProtKB/Swiss-Prot: VAR_054906; dbSNP: rs281875276
NCBI 1000 Genomes Browser:
rs281875276
Molecular consequence:
  • NM_000128.4:c.1853T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_033900.1:n.905A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000090543UniProtKB/Swiss-Prot
no classification provided
not providednot providednot provided

PubMed (1)
[See all records that cite this PMID]

SCV005078719GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Dec 11, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providednot providednot providednot providednot providednot provided1not providedliterature only

Citations

PubMed

Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction-based test to define a whole gene deletion.

Hill M, McLeod F, Franks H, Gordon B, Dolan G.

Br J Haematol. 2005 Jun;129(6):825-9.

PubMed [citation]
PMID:
15953011

Details of each submission

From UniProtKB/Swiss-Prot, SCV000090543.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not providednot provided1not providednot providednot providednot providednot providednot provided

From GeneDx, SCV005078719.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19652879, 16835901, 15953011)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024